Benign neoplasm of brain and other parts of central nervous system

DOID EFO MESH PheWeb

CD2_BENIGN_BRAIN_CNS

brain neoplasm: A neoplasm (disease) that involves the brain.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 D33

Cause of death: ICD-10 D33

1245

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10 ; C.O.D: 10

1245

Check minimum number of events None

1245

Include endpoints

CD2_BENIGN_BRAIN_SUPRATENT

CD2_BENIGN_BRAIN_INFRATENT

CD2_BENIGN_BRAIN_NOS

CD2_BENIGN_CRANIAL_NERVE

CD2_BENIGN_SPINAL_CORD

CD2_BENIGN_CNS_NOS

1391

CD2_BENIGN_BRAIN_CNS

Extra metadata

Level in the ICD hierarchy 2

First used in FinnGen datafreeze DF2

Parent code in ICD-10 D10-D36

Name in latin Neoplasmata benigna systematis nervosi centralis et nervorum cranialium

Similar endpoints

↥

List of similar endpoints to Benign neoplasm of brain and other parts of central nervous system based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	1345	752	593
Unadjusted prevalence (%)	0.44	0.43	0.44
Mean age at first event (years)	51.08	50.20	52.19

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.04	2.92 [1.97, 4.32]	9.9e-8	105
15 years	0.01	1.49 [0.97, 2.30]	6.7e-2	43
5 years	0.00	2.57 [1.59, 4.14]	1.1e-4	24
1 year	0.00	6.38 [3.27, 12.46]	5.6e-8	12

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_BENIGN_BRAIN_CNS – Benign neoplasm of brain and other parts of central nervous system
GWS hits: 1

Survival analyses between endpoints

↥

Plot

before Benign neoplasm of brain and other parts of central nervous system
after Benign neoplasm of brain and other parts of central nervous system

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Benign neoplasm of brain and other parts of central nervous system

↥